Parenteral Drug (India) share news and announcements

BSE: 524689Pharmaceuticals & Biotechnology

Trading suspended since 3 Feb 2025

Last traded ₹2.90 on 21 Aug 2023

Parenteral Drug (India) share news and announcements

782 announcements, routine notices left out, newest first. Page 6 of 16.

Jul 2020
- 29 Jul · Board meeting
  Parenteral Drugs (India) Limited hereby submits outcome of the Board Meeting held on 29th July, 2020 which inter-alia considered, approved and took on record the Audited Annual Financial .... (opens in a new tab)
- 29 Jul · Board meeting
  Board meeting held on July 29, 2020. (opens in a new tab)
- 23 Jul · Updates
  Announcement under Regulation 30 (LODR)- Newspaper Publication regarding Clippings of Newspaper Notice published pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015 (opens in a new tab)
- 22 Jul · Board meeting
  To consider the Audited Financial Results (Both Standalone and Consolidated) of the Company for the financial year ended on 31st March, 2020. (opens in a new tab)
- 22 Jul · Board meeting
  PARENTERAL DRUGS (INDIA) LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2020 ,inter alia, to consider and approve the Audited Financial .... (opens in a new tab)
- 21 Jul · Shareholding for the Period Ended June 30, 2020
  Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....
- 21 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 6 Jul · Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015-Updates
  Appointment of Mr. Vinod Kumar Gupta (opens in a new tab)
Jun 2020
May 2020
- 28 May · Compliances- Certificate Under Regulation 40 (10) Of SEBI (LODR) Regulations, 2015
  Parenteral Drugs (India) Limited hereby submit Certificate under Regulation 40 (10) of SEBI (LODR) Regulations, 2015 for the half year ended on 31st March, 2020. (opens in a new tab)
- 26 May · Compliances-Compliance Certificate For The Period Ended March, 2020
  Parenteral Drugs (India) Limited hereby submit Certificate pursuant to Regulation 7 (3) of SEBI (LODR) Regulations, 2015 for the half year ended 31st March, 2020. (opens in a new tab)
- 26 May · Compliances-Compliance Certificate For The Period Ended March, 2020
  Parenteral Drugs (India) Limited hereby submit Certificate pursuant to Regulation 7 (3) of SEBI (LODR) Regulations, 2015 for the half year ended 31st March, 2020. (opens in a new tab)
- 16 May · Shareholding for the Period Ended March 31, 2020
  Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click ....
- 15 May · Statement Of Investor Complaints For The Quarter Ended March 2020
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Apr 2020
- 27 Apr · Corrigendum
  Corrigendum to intimation submitted w.r.t. Acceptance of One Time Loan Settlement proposal on 25th April, 2020 (opens in a new tab)
- 27 Apr · Announcement Under Regulation 30 (LODR) Updates- (OTS)
  Corrigendum to intimation submitted w.r.t. Acceptance of One Time Loan Settlement proposal on 25th April, 2020 (opens in a new tab)
- 25 Apr · Updates
  Announcement under Regulation 30 with respect to One time settlement (opens in a new tab)
- 25 Apr · Announcemet Under Regulation 30 (LODR)- Updates
  Parenteral Drugs (India) Limited hereby inform the exchange regarding acceptance of proposal of one time settlement against the outstanding debts of the Company. (opens in a new tab)
Feb 2020
Jan 2020
- 31 Jan · Updates
  Announcement under Regulation 30 (LODR)-Newspaper Publication regarding Clippings of Newspaper Notice published pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015 (opens in a new tab)
- 30 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2019 and other business matters (opens in a new tab)
- 30 Jan · Board meeting
  PARENTERAL DRUGS (INDIA) LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2020 ,inter alia, to consider and approve unaudited quarterly .... (opens in a new tab)
- 20 Jan · Shareholding for the Period Ended December 31, 2019
  Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click ....
- 18 Jan · Updates
  Certificate for quarter ended 31st December, 2019 pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 . (opens in a new tab)
- 17 Jan · Statement Of Investor Complaints For The Quarter Ended December 2019
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 3 3 0
Nov 2019
- 26 Nov · Related Party Transactions
  Disclosure of Related Party Transactions under Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2019. (opens in a new tab)
- 26 Nov · Disclosure Of Related Party Transactions For Half Year Ended 30Th September, 2019
  Parenteral Drugs (India) Limited hereby submits Disclosure of Related Party Transactions for the half year ended 30th September, 2019. (opens in a new tab)
- 13 Nov · Results
  Parenteral Drugs (India) Limited hereby submits unaudited quarterly financial results on standalone and consolidated basis for the quarter ended 30th September, 2019. (opens in a new tab)
- 13 Nov · Results
  Financial results for the period ended September 30, 2019. (opens in a new tab)
- 13 Nov · Board meeting
  Board meeting held on November 13, 2019. (opens in a new tab)
- 13 Nov · Board meeting
  Parenteral Drugs (India) Limited hereby submits outcome of the Board Meeting held on 13th November, 2019. (opens in a new tab)
- 5 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2019 (opens in a new tab)
- 5 Nov · Board meeting
  PARENTERAL DRUGS (INDIA) LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2019 ,inter alia, to consider and approve unaudited quarterly .... (opens in a new tab)
Oct 2019
- 24 Oct · Updates
  Revised Compliance Certificate pursuant to Regulation 40(10) of SEBI (LODR) Regulations, 2015 (opens in a new tab)
- 23 Oct · Compliances-Revised Compliance Certificate Pursuant To Regulation 40(10) Of SEBI (LODR) Regulations, 2015
  Parenteral Drugs (India) Limited hereby submits revised Compliance Certificate pursuant to Regulation 40(10) of SEBI (LODR) Regulations, 2015 (opens in a new tab)
- 23 Oct · Compliances- Regulation 40(9)
  Parenteral Drugs (India) Limited hereby submits Compliance Certificate pursuant to Regulation 40(10) of SEBI (LODR) Regulations, 2015. (opens in a new tab)
- 22 Oct · Shareholding for the Period Ended September 30, 2019
  Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click ....
- 19 Oct · Compliances- Compliance Certificate For The Period Ended 30Th September, 2019
  Parenteral Drugs (India) Limited hereby submits Compliance Certificate pursuant to Regulation 7(3) of SEBI (LODR) Regulations, 2015. (opens in a new tab)
- 19 Oct · Updates
  Confirmation Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. (opens in a new tab)
- 19 Oct · Statement Of Investor Complaints For The Quarter Ended September 2019
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 2 2 0
- 10 Oct · Disclosure
  Reason for encumbrance vide letter dated October 04, 2019 under SEBI ( SAST) Regulations, 2011. (opens in a new tab)
- 9 Oct · Disclosure
  Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October .... (opens in a new tab)
Sep 2019
- 2 Sep · Results
  Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2019
- 31 Aug · Results
  Parenteral Drugs (India) Limited hereby intimates voting results on business transacted at the 35th Annual General Meeting of the Company held on 31st August, 2019. (opens in a new tab)
- 31 Aug · Management
  Reappointment of Director of the company. (opens in a new tab)